Filter your results
- 3
- 1
- 4
- 4
- 1
- 1
- 1
- 1
- 4
- 2
- 1
- 1
- 1
- 1
- 1
- 4
- 4
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolatesVaccine, 2020, 38 (47), pp.7542 - 7550. ⟨10.1016/j.vaccine.2020.09.050⟩
Journal articles
pasteur-03265134v1
|
||
|
Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic VaccinemBio, 2018, 9 (2), ⟨10.1128/mBio.00036-18⟩
Journal articles
pasteur-01950865v1
|
||
|
Evolutionary Events Associated with an Outbreak of Meningococcal Disease in Men Who Have Sex with Men.PLoS ONE, 2016, 11 (5), pp.e0154047. ⟨10.1371/journal.pone.0154047⟩
Journal articles
pasteur-01351740v1
|
||
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.The Lancet Infectious Diseases, 2013, 13 (5), pp.416-425. ⟨10.1016/S1473-3099(13)70006-9⟩
Journal articles
pasteur-02093031v1
|